CGFNS International
23.2.2024 21:03:16 CET | ACCESS Newswire | Press release
PHILADELPHIA, PA / ACCESSWIRE / February 23, 2024 / CGFNS International announced today it has established a Global Health Workforce Development Institute. The new think tank will conduct original research and leverage knowledge developed by CGFNS over its half-century of providing credentialing services -- as well as its vast experience with workforce mobility issues -- to advance scientific knowledge about the evolution of health workforce roles and the development of credentialing and certification programs and policies.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.A long-term objective of the Institute will be to create rigorous global certification programs that streamline the assessment and recognition of practice competency. These will empower nurses and other health professionals around the world to achieve "work-readiness" regardless of where they choose to apply their knowledge and skills, while enabling them to showcase their competencies to employers, regulators, and educators worldwide.
"Amid an unprecedented health workforce crisis, and with an increasing number of health workers being displaced by the impacts of climate change and armed conflict, the patchwork quilt of standards and qualifications between countries threatens to prevent health workers from practicing to their capacities, much less helping to alleviate workforce shortages in high-need countries and improve healthcare access for underserved populations," said Peter Preziosi, President and CEO of CGFNS.
"This new Institute will be the centerpiece of our effort to address this challenge and ease mobility for health workers to practice where they want and where they are needed," he added.
Leading the new Institute as its Chief is Julia To Dutka, EdD, a renowned global expert and strategist in credential assessment and global labor mobility who is widely published in the fields of education, regulation, and language teaching and testing. Dr. To Dutka brings to the Institute a unique integration of experience from her many years of service at CGFNS, as well as from higher education and from the assessment industry, where she has led large-scale global assessment initiatives.
The Institute will comprise three centers of excellence:
- The Center for Global Assessment and Certification will lead efforts in the setting of global standards and assessment of competencies in the health professions. Its senior director, Joseph McClintock, PhD, has more than 20 years' experience in all aspects of certification and educational assessment, including test design and creation, item and test development, standards setting and job task analysis. He joins the Institute after serving as vice president of Measurement, Inc., a leading provider of customized educational assessment services.
- The Center for Knowledge Management will manage CGFNS International's extensive international education and health regulatory databases, along with other knowledge assets, with a focus on leveraging the educational and regulatory data to advance initiatives, policies and further research in global health workforce development. Its senior director, Emily Tse, MPhil, is a recognized expert in the credential evaluation field who previously managed the Country Index series on educational systems around the world at the International Education Research Foundation (IERF).
- The Center for Global Research and Policy will catalyze a robust research and development agenda and contribute to global human resources for health scholarship through inquiry around global health workforce development, care delivery, and lifelong learning issues. Its senior director, Lauren Herckis, PhD, joins CGFNS from the faculty of Carnegie Mellon University, where she has led interdisciplinary research efforts focused on evidence-based practice for using emerging educational technologies across diverse cultural contexts.
"With our nearly 50-year mission of evaluating nurses and allied health professionals who have chosen to live and work in their country of choice through assessment protocols centering on academic and professional credentials, it is time for CGFNS to recommit itself to improving the health and well-being of the world's populations," said To Dutka. "The Institute will enable CGFNS to serve as a thought leader, to advance new and innovative certification systems, and to support models of care delivery that will accelerate health workforce growth and evolution worldwide."
About CGFNS International, Inc.
Founded in 1977 and based in Philadelphia, CGFNS International is an immigration-neutral not-for-profit organization proudly serving as the world's largest credentials evaluation organization for the nursing and allied health professions. CGFNS International is an NGO in Consultative Status with the United Nations Economic and Social Council (ECOSOC) and is a member of the Conference of NGOs in Consultative Relationship with the United Nations (CoNGO).
Contact Information:
David St. John
dstjohn@cgfns.org
SOURCE: CGFNS International
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
PharmaNest and Mediar Therapeutics Collaborate to Quantify ECM and Fibrosis Remodeling in the EncompaSSc Phase 2 Trial of MTX-474 in Diffuse Cutaneous Systemic Sclerosis30.9.2026 19:00:00 CEST | Press release
PRINCETON, NJ / ACCESS Newswire / September 30, 2026 / PharmaNest, Inc. an AI-enabled digital pathology company specializing in the quantitative and spatial characterization of fibrosis and Mediar Therapeutics, Inc., a clinical-stage biotechnology company pioneering first-in-class therapies to halt and reverse fibrosis, today announced a collaboration to integrate advanced digital pathology into Mediar's ongoing EncompaSSc Phase 2 clinical trial of MTX-474 in patients with diffuse cutaneous systemic sclerosis (dcSSc). MTX-474 is a first-in-class human IgG1 monoclonal antibody designed to neutralize EphrinB2 signaling, a pathway implicated in myofibroblast activation, extracellular matrix (ECM) deposition and tissue remodeling known to drive fibrosis in SSc. The randomized, double-blind, placebo-controlled EncompaSSc Phase 2 study is evaluating the safety and efficacy of MTX-474 in patients with dcSSc. Under the collaboration, PharmaNest will apply its FibroNest™ AI-enabled digital path
Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans30.9.2026 15:50:00 CEST | Press release
NEW YORK, NY / ACCESS Newswire / September 30, 2026 / Innodata Inc. (Nasdaq:INOD) today announced the opening of a new R&D laboratory that is designed to generate the data needed to train the next generation of human-like robots and independently validate the performance data that robots generate internally. Innodata developed the lab in collaboration with Vicon, a leader in motion capture who consulted on the lab design and continues to provide technical consulting. The New Jersey-based lab is equipped with high-precision, low-latency infrared optical tracking cameras that measure movement down to the sub-millimeter level-a degree of accuracy that methods such as wearable inertial measurement unit (IMU) sensors and single-camera (monocular) video analysis typically cannot match. The lab addresses an urgent need for high-quality training data for humanoids, industrial robots, and other forms of physical AI. While many other data providers infer 3D motion by analyzing 2D video, Innodata
Clean Air Metals Files Interim Financial Statements for the Six Months Ended July 31, 202630.9.2026 00:45:00 CEST | Press release
THUNDER BAY, ON / ACCESS Newswire / September 29, 2026 / Clean Air Metals Inc. ("Clean Air Metals" or the "Company") (TSXV:AIR)(FRA:CKU)(OTC PINK:CLRMF) announces that it has filed its unaudited consolidated interim financial statements and management's discussion and analysis for the six-month period ended July 31, 2026, available for viewing on www.sedarplus.ca. Financial HighlightsTotal assets as at July 31, 2026 of $35,465,204Total cash as at July 31, 2026 of $422,500Working capital deficiency as at July 31, 2026 of $3,188,114Shareholder's equity as at July 31, 2026 of $31,803,864 During the six-month period ended July 31, 2026, the Company incurred $164,309 in cost for exploration activities at the Thunder Bay North project. During the second fiscal quarter, the Company focused on finalizing the proposed amalgamation while continuing discussions on Advanced Exploration permitting and re-assessment of past geophysical work to highlight areas of focus for drilling and geophysics in
Continent 8 and FuturePath AI Launch Future8: Accountable AI for Regulated Industries29.9.2026 15:00:00 CEST | Press release
LISBON, PT / ACCESS Newswire / September 29, 2026 / Continent 8 Technologies and FuturePath AI today launched Future8, an AI-native operating company built for regulated operators, formed as a joint venture between the two companies. Announced at SBC Summit Lisbon, Future8 combines FuturePath's enterprise AI applications platform with Continent 8's licensed global operating footprint, enabling the iGaming industry to deploy auditable AI without compromising compliance, data sovereignty and operational control. Built for highly regulated environments, Future8 enables operators to move from AI experimentation to production deployment by embedding governance, approvals and auditability into every workflow from day one. Continent 8 brings licensed data centers and a private global network spanning more than 100 locations, built over 28 years serving the biggest iGaming and online brands, along with AI-enabled Global Capability Centers in India, the Philippines and Bulgaria. The company als
Europe SPAC Summit 2026 Invites European Private Companies to Explore the SPAC Path to U.S. Public Markets29.9.2026 15:00:00 CEST | Press release
NEW YORK, NY AND ZURICH, SWITZERLAND / ACCESS Newswire / September 29, 2026 / A growing number of European companies in frontier technologies, critical minerals, advanced manufacturing, defense tech, energy, and consumer sectors are evaluating a merger with a special purpose acquisition company (SPAC) as a faster route to a U.S. listing, a valuation that reflects global investor demand, and access to follow-on capital. The Europe SPAC Summit 2026 (ESPAC'26), co-hosted by AUM Advisors and MBP Global, is inviting the CEOs, CFOs, founders, and board members of late-stage European private companies to The Dolder Grand in Zurich on Thursday, December 10, 2026, to learn how the process works and to meet the investment bankers, institutional investors, and SPAC sponsors who make these transactions happen. Attendance is by invitation only and free of charge for qualified companies. Europe's recent de-SPACs show what is possible. Kyivstar, Ukraine's largest mobile operator, listed on Nasdaq thr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
